14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026
HIG vs ACGL: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
As of Nov 16, 2026, The Hartford Insurance Group, Inc. (HIG) is the stronger overall head-to-head candidate over Arch Capital Group Ltd (ACGL) in the Tradestie Institutional Equity Comparison Engine, winning 5–4 core matrix metrics and 4–2 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Options & Positioning). HIG carries a Unified Composite Score of 54.7/100 (HOLD) at $137.12 (10.1x Forward P/E, 19.0% operating margin), whereas ACGL carries 36.4/100 (SELL) at $110.30 (11.0x Forward P/E, 27.1% operating margin).
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on HIG vs ACGL. Trailing 12-month operating profitability (HIG 19.0% vs ACGL 27.1%) and valuation multiples (HIG 10.1x vs ACGL 11.0x Forward P/E) are benchmarked directly in Pillar 4 below.
Competes within the Insurance - Diversified value chain with $35.6B market capitalization and 27.1% operating margin.
OpEx & R&D Reinvestment10.5% of Rev ($1.97B)
90D Engineering Disclosures0 Published
Investor FAQ HIG vs ACGL Key Questions & Quantitative Answers
As of Nov 16, 2026, The Hartford Insurance Group, Inc. (HIG) is the stronger overall head-to-head candidate over Arch Capital Group Ltd (ACGL) in the Tradestie Institutional Equity Comparison Engine, winning 5–4 core matrix metrics and 4–2 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Options & Positioning). HIG carries a Unified Composite Score of 54.7/100 (HOLD) at $137.12 (10.1x Forward P/E, 19.0% operating margin), whereas ACGL carries 36.4/100 (SELL) at $110.30 (11.0x Forward P/E, 27.1% operating margin). Technically, HIG sits in a Neutral phase (RSI 58.1, UNCLASSIFIED options structure) and ACGL sits in a Markup phase (RSI 68.5, UNCLASSIFIED options structure).
HIG leads the Growth & Scale pillar: HIG posts +3.9% YoY revenue growth and +28.0% YoY earnings growth on $29.6B TTM revenue (38.6% gross margin, 19.0% operating margin), compared with ACGL at -8.9% YoY revenue growth and -15.7% YoY earnings growth on $18.8B TTM revenue (37.6% gross margin, 27.1% operating margin). On trailing 12-month operating scale, HIG generates $29.6B in USD-normalized revenue versus $18.8B for ACGL. In operating R&D and SG&A reinvestment, HIG deploys 19.6% of Rev ($5.80B) (0 90-day corporate R&D disclosures) versus 10.5% of Rev ($1.97B) (0 disclosures) for ACGL.
HIG screens cheaper on headline valuation multiples. HIG trades at 10.1x Forward P/E, 9.2x Trailing P/E, 0.12x PEG, and 1.4x EV/Revenue (23.5% FCF margin), whereas ACGL trades at 11.0x Forward P/E, 8.9x Trailing P/E, 1.05x PEG, and 1.9x EV/Revenue (27.8% EBITDA margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against HIG (23.2% ROE) versus ACGL (18.7% ROE) capital efficiency.
In options market volatility and institutional positioning, HIG carries 18.9% implied volatility (7th %ile, Compressed (<25th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (-0.14β · 25% Vol realized risk). By comparison, ACGL carries 21.3% implied volatility (39th %ile, Balanced (25th–60th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (-0.26β · 25% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.